Suchergebnisse - "Zhong, Nanshan"

PubPharm (39)

1

Efficacy and safety of GST-HG171 in adult patients with mild to moderate COVID-19 : a randomised, double-blind, placebo-controlled phase 2/3 trial

enthalten in: EClinicalMedicine | 2024

von Lu, H. | Zhang, G. | Mao, J. | +34

2

Profiles of Cough and Associated Risk Factors in Nonhospitalized Individuals With SARS-CoV-2 Omicron Variant Infection : Cross-Sectional Online Survey in China

enthalten in: JMIR public health and surveillance | 2024

von Xu, T. | Chen, Y. | Zhan, W. | +35

3

Leritrelvir for the treatment of mild or moderate COVID-19 without co-administered ritonavir : a multicentre randomised, double-blind, placebo-controlled phase 3 trial

enthalten in: EClinicalMedicine | 2024

von Zhan, Y. | Lin, Z. | Liang, J. | +37

4

Plasma cell-free DNA promise monitoring and tissue injury assessment of COVID-19

enthalten in: Molecular genetics and genomics : MGG | 2023

von Jin, X. | Wang, Y. | Xu, J. | +43

5

Phospholipid remodeling and its derivatives are associated with COVID-19 severity

enthalten in: The Journal of allergy and clinical immunology | 2023

von Wei, J. | Liu, X. | Xiao, W. | +13

6

Plasma cell-free DNA promise monitoring and tissue injury assessment of COVID-19

enthalten in: Molecular genetics and genomics | 2023

von Jin, X. | Wang, Y. | Xu, J. | +43

7

Heterologous booster with inhaled adenovirus vector COVID-19 vaccine generated more neutralizing antibodies against different SARS-CoV-2 variants

enthalten in: Emerging microbes & infections | 2022

von Zhong, J. | Liu, S. | Cui, T. | +6

8

Risk factors for impaired pulmonary diffusion function in convalescent COVID-19 patients : A systematic review and meta-analysis

enthalten in: EClinicalMedicine | 2022

von Zhi, H. | Ji, X. | Zhao, Z. | +12

9

Quantifying the Effect of Public Activity Intervention Policies on COVID-19 Pandemic Containment Using Epidemiologic Data From 145 Countries

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2022

von Sun, J. | Zheng, Y. | Liang, W. | +7

10

Crucial control measures to contain China's first Delta variant outbreak

enthalten in: National science review | 2022

von Luo, L. | Yang, Z. | Liang, J. | +27